History
The mitochondrial folate transporter was first described in 2000.[3]
Role in pathology
Mutations of the SLC25A32 gene cause the condition putatively called "riboflavin-responsive exercise intolerance" (RREI), also known as SLC25A32 deficiency. The first case report linking this condition to SLC25A32 was published in 2016.[4] Several additional cases of SLC25A32 deficiency have been described since.[5][6] The phenotype of the patients is reminiscent of multiple acyl-CoA dehydrogenase deficiency (MADD).
According to a review published in 2020, mutations of the SLC25A32 gene have been shown to cause neural tube defects in mice, and they have been associated with several human cases, based on a re-sequencing of DNA of patients with neural tube defects.[7]
References
- ↑ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ↑ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ↑ Titus SA, Moran RG (November 2000). "Retrovirally mediated complementation of the glyB phenotype. Cloning of a human gene encoding the carrier for entry of folates into mitochondria". The Journal of Biological Chemistry. 275 (47): 36811–7. doi:10.1074/jbc.M005163200. PMID 10978331.
- ↑ Schiff M, Veauville-Merllié A, Su CH, Tzagoloff A, Rak M, Ogier de Baulny H, Boutron A, Smedts-Walters H, Romero NB, Rigal O, Rustin P, Vianey-Saban C, Acquaviva-Bourdain C (February 2016). "SLC25A32 Mutations and Riboflavin-Responsive Exercise Intolerance". The New England Journal of Medicine. 374 (8): 795–7. doi:10.1056/NEJMc1513610. PMC 4867164. PMID 26933868.
- ↑
- ↑ Al Shamsi B, Al Murshedi F, Al Habsi A, Al-Thihli K (November 2021). "Hypoketotic hypoglycemia without neuromuscular complications in patients with SLC25A32 deficiency". European Journal of Human Genetics. 30 (8): 976–979. doi:10.1038/s41431-021-00995-7. PMC 9349259. PMID 34764427.
- ↑ Steele JW, Kim SE, Finnell RH (June 2020). "One-carbon metabolism and folate transporter genes: Do they factor prominently in the genetic etiology of neural tube defects?". Biochimie. 173: 27–32. doi:10.1016/j.biochi.2020.02.005. PMC 7253344. PMID 32061804.
|
|---|
By group |
|---|
SLC1–10 |
|---|
| (1): | |
|---|
| (2): | |
|---|
| (3): | |
|---|
| (4): | |
|---|
| (5): | |
|---|
| (6): | |
|---|
| (7): | |
|---|
| (8): | |
|---|
| (9): | |
|---|
| (10): |
- Sodium bile salt cotransport
|
|---|
|
| SLC11–20 |
|---|
| (11): |
- Proton coupled metal ion transporter
|
|---|
| (12): | |
|---|
| (13): |
- human Na+-sulfate/carboxylate cotransporter
|
|---|
| (14): | |
|---|
| (15): |
- Proton oligopeptide cotransporter
|
|---|
| (16): |
- Monocarboxylate transporter
|
|---|
| (17): | |
|---|
| (18): | |
|---|
| (19): | |
|---|
| (20): | |
|---|
|
| SLC21–30 |
|---|
| (21): | |
|---|
| (22): | |
|---|
| (23): |
- Na+-dependent ascorbic acid transporter
|
|---|
| (24): | |
|---|
| (25): | |
|---|
| (26): |
- Multifunctional anion exchanger
|
|---|
| (27): | |
|---|
| (28): |
- Na+-coupled nucleoside transport
|
|---|
| (29): |
- Facilitative nucleoside transporter
|
|---|
| (30): | |
|---|
|
| SLC31–40 |
|---|
| (31): | |
|---|
| (32): | |
|---|
| (33): | |
|---|
| (34): |
- type II Na+-phosphate cotransporter
|
|---|
| (35): |
- Nucleoside-sugar transporter
-
-
-
-
- SLC35E1
- SLC35E2
- SLC35E3
- SLC35E4
|
|---|
| (36): | |
|---|
| (37): |
- Sugar-phosphate/phosphate exchanger
|
|---|
| (38): |
- System A & N, sodium-coupled neutral amino-acid transporter
|
|---|
| (39): | |
|---|
| (40): |
- Basolateral iron transporter
|
|---|
|
| SLC41–48 |
|---|
| (41): | |
|---|
| (42): | |
|---|
| (43): |
- Na+-independent, system-L like amino-acid transporter
|
|---|
| (44): | |
|---|
| (45): |
- Putative sugar transporter
|
|---|
| (46): | |
|---|
| (47): | |
|---|
| (48): | |
|---|
|
| |
|
|
|
see also solute carrier disorders |